Astellas Pharma | 4503 - Net Income


Astellas Pharma reported JPY141.83B in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Astellas Pharma JPY 141.83B 98.31B Jun/2026
Chugai Pharma JPY 116.33B 913M Jun/2026
Daiichi Sankyo JPY 68.64B 18B Jun/2026
Eisai JPY 18.24B 21.49B Jun/2026
Kyowa Hakko Kirin JPY 18.58B 6.55B Jun/2026
M3 JPY 9.07B 1.62B Jun/2026
Otsuka Holdings JPY 117.26B 18.92B Jun/2026
Shionogi JPY 97.7B 50.76B Jun/2026
Sumitomo Dainippon JPY 17B 17.81B Jun/2026
Takeda JPY 113.2B 137.52B Jun/2026
Terumo JPY 70.43B 44.06B Jun/2026